over 2500 people
have chosen eloctate
with their doctor.*

Get to know the ELOCTATE Peers and see how ELOCTATE has impacted their lives.

*Data on file. Waltham, MA; Bioverativ Therapeutics Inc., an affiliate of Sanofi.

Jenny wants to protect her son's joints from bleeds now, and as he gets older.

see their story

Kenny keeps his body and joints protected from bleeds on the road with ELOCTATE.

see kenny's story

ELOCTATE helps keep DJ's joints in rhythm and protected from bleeds.

see dj's story

Ryan made the move to protect his joints and help prevent bleeds on a prophy regimen with ELOCTATE.

see ryan's story

When it comes to joint bleed protection, Chet’s son Caleb gets the coverage he needs on the court.

see their story

Craig and his doctor chose prophy with ELOCTATE to protect his body and his joints from bleeds after treating on-demand for decades.

see craig's story

Jonathan switched from ADVATE® to ELOCTATE.

see jonathan's story

Note: These are personal accounts of ELOCTATE Peers. Please talk to your healthcare provider about whether ELOCTATE may be right for you. Individual results may vary.

*The recommended starting regimen is 50 IU/kg every 4 days as directed by your doctor. In children under 6 years of age, the recommended starting regimen is 50 IU/kg administered twice weekly. The regimen can be adjusted based on your body's individual response.

† ELOCTATE has been proven to help patients prevent bleeding episodes using a prophylaxis regimen.

ADVATE® [Antihemophilic Factor (Recombinant)] is a registered trademark of Baxalta Incorporated, a Takeda company.

Do you or someone you care about have experience on ELOCTATE? Become an ELOCTATE Peer

eloctate 101:
get the basics

learn more

interested in financial
assistance programs?

find out more

questions for your
doc about switching

get started

Got more questions? Contact your CoRe.

Community Relations and Education Managers (or CoRe, for short) live and work all across the United States. CoRe team members are advocates and people with decades of experience in Hemophilia. They're available to answer your questions, educate, or just to talk. Use our handy CoRe Locator to find the CoRe team member nearest you.

×

INDICATIONS ELOCTATE® [Antihemophilic Factor (Recombinant), Fc Fusion Protein] is an injectable medicine that is used to help control and prevent bleeding in people with Hemophilia A (congenital Factor VIII deficiency). Your healthcare provider may give you ELOCTATE when you have surgery.

Important Safety Information and Indications 

IMPORTANT SAFETY INFORMATION

Do not use ELOCTATE if you have had an allergic reaction to it in the past.

Tell your healthcare provider if you have or have had any medical problems, take any medicines, including prescription and non-prescription medicines, supplements, or herbal medicines, have any allergies, are breastfeeding, are pregnant or planning to become pregnant, or have been told you have inhibitors (antibodies) to Factor VIII.

INDICATIONS

ELOCTATE® [Antihemophilic Factor (Recombinant), Fc Fusion Protein] is an injectable medicine that is used to help control and prevent bleeding in people with Hemophilia A (congenital Factor VIII deficiency). Your healthcare provider may give you ELOCTATE when you have surgery.

Important Safety Information and Indications 

IMPORTANT SAFETY INFORMATION

Do not use ELOCTATE if you have had an allergic reaction to it in the past.

Tell your healthcare provider if you have or have had any medical problems, take any medicines, including prescription and non-prescription medicines, supplements, or herbal medicines, have any allergies, are breastfeeding, are pregnant or planning to become pregnant, or have been told you have inhibitors (antibodies) to Factor VIII.

Allergic reactions may occur with ELOCTATE. Call your healthcare provider or get emergency treatment right away if you have any of the following symptoms: difficulty breathing, chest tightness, swelling of the face, rash, or hives.

Your body can also make antibodies called "inhibitors" against ELOCTATE, which may stop ELOCTATE from working properly.

The most frequently occurring side effects of ELOCTATE are headache, rash, joint pain, muscle pain and general discomfort. These are not all the possible side effects of ELOCTATE. Talk to your healthcare provider right away about any side effect that bothers you or that does not go away, and if bleeding is not controlled after using ELOCTATE.

Please see Full Prescribing Information

MANUFACTURED BY

Bioverativ Therapeutics Inc.
Waltham, MA 02451 USA
U.S. License #2078

Click here to learn more about Sanofi's commitment to fighting counterfeit drugs.

INDICATIONS

ELOCTATE® [Antihemophilic Factor (Recombinant), Fc Fusion Protein] is an injectable medicine that is used to help control and prevent bleeding in people with Hemophilia A (congenital Factor VIII deficiency). Your healthcare provider may give you ELOCTATE when you have surgery.